Evidence map›Paper›PMID 35861625›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2022

Pediatric Cancer By Race, Ethnicity and Region in the United States.

Judy R Rees, Julie E Weiss, Bruce L Riddle, Karen Craver, Michael Scot Zens, Maria O Celaya, Janet L Peacock

Open access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Judy R ReesDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.ORCID 0000-0002-8232-1056
Julie E WeissDartmouth Cancer Center, Lebanon, New Hampshire.ORCID 0000-0002-8274-5991
Bruce L RiddleDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.ORCID 0000-0002-4894-0160
Karen CraverNew Hampshire Department of Environmental Services, Concord, New Hampshire.ORCID 0000-0003-0831-2597
Michael Scot ZensDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.ORCID 0000-0002-7396-7701
Maria O CelayaDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.ORCID 0000-0001-5362-2928
Janet L PeacockDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.ORCID 0000-0002-0310-2518
Dartmouth College · USNew Hampshire Fish and Game Department · US

Funding

CDC HHS NU58DP006298
6 · The paper itself

Abstract

backgroundIn a 2018 descriptive study, cancer incidence in children (age 0-19) in diagnosis years 2003 to 2014 was reported as being highest in New Hampshire and in the Northeast region.

methodsUsing the Cancer in North America (CiNA) analytic file, we tested the hypotheses that incidence rates in the Northeast were higher than those in other regions of the United States either overall or by race/ethnicity group, and that rates in New Hampshire were higher than the Northeast region as a whole.

resultsIn 2003 to 2014, pediatric cancer incidence was significantly higher in the Northeast than other regions of the United States overall and among non-Hispanic Whites and Blacks, but not among Hispanics and other racial minorities. However, there was no significant variability in incidence in the states within the Northeast overall or by race/ethnicity subgroup. Overall, statistically significantly higher incidence was seen in the Northeast for lymphomas [RR, 1.15; 99% confidence interval (CI), 1.10-1.19], central nervous system neoplasms (RR, 1.12; 99% CI, 1.07-1.16), and neuroblastoma (RR, 1.13; 99% CI, 1.05-1.21).

conclusionsPediatric cancer incidence is statistically significantly higher in the Northeast than in the rest of the United States, but within the Northeast, states have comparable incidence. Differences in cancer subtypes by ethnicity merit further investigation. IMPACT: Our analyses clarify and extend previous reports by statistically confirming the hypothesis that the Northeast has the highest pediatric cancer rates in the country, by providing similar comparisons stratified by race/ethnicity, and by assessing variability within the Northeast.

Indexed as

EthnicityNeoplasmsAdolescentAdultChildChild, PreschoolHispanic or LatinoHumansIncidenceInfantInfant, NewbornRacial GroupsUnited StatesWhite PeopleYoung Adult

Identifiers

PMID35861625
PMCPMC9578755
OpenAlexW4286497185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.